Literature DB >> 3165255

Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).

I Fukazawa1, N Inaba, Y Ota, N Sato, S Shirotake, H Iwasawa, S Sekiya, H Takamizawa, N Suzuki, H Tokita.   

Abstract

The patient was a 57-year-old woman with ovarian serous cystadenocarcinoma in FIGO clinical stage IV. Cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) were immunohistochemically demonstrated in tumor cells, and the variations of serum CA125 and TPA levels reflected the clinical course. The tumor tissue obtained at exploratory laparotomy was minced with scissors, and transplanted subcutaneously into female nude mice for in vivo maintenance. The tumor cells from 5th generation nude mice were dispersed in Eagle's minimal essential medium supplemented with 10% fetal calf serum, and incubated in Falcon tissue culture dishes at 37 degrees C in 5% CO2 in air for in vitro maintenance. The results were as follows: Histopathologically the tumor transplanted into nude mice showed a cystadenocarcinoma, which closely resembled the original human tumor. Immunohistochemically CA125, TPA and CEA were demonstrated in the tumor transplanted into nude mice as well as in the original human tumor. From the growth curve in nude mice, the doubling time was estimated to be about 3.5 days. Serum TPA levels in nude mice were increased in proportion to the tumor growth after transplantation, but serum levels CA125 and CEA were normal. The concentrations of CA125 and TPA were increased in the conditioned media compared with the control media, although the elevated values were decreased with subsequent passages. CEA concentrations in the conditioned media were unchanged.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165255     DOI: 10.1007/bf00932972

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  14 in total

1.  Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique; presence of an insoluble, heat-labile tumor antigen.

Authors:  B BJORKLUND; V BJORKLUND
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

2.  Two new tissue culture lines from ovarian cancer.

Authors:  P J DiSaia; M Morrow; J Kanabus; W Piechal; D E Townsend
Journal:  Gynecol Oncol       Date:  1975-09       Impact factor: 5.482

3.  Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease.

Authors:  I Fukazawa; N Inaba; Y Ota; N Sato; S Shirotake; H Iwasawa; T Sato; H Takamizawa; B Wiklund
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  [Establishment and characterization of a cell line derived from mucinous cystadenocarcinoma of human ovary].

Authors:  Y Kidera; T Yoshimura; Y Ohkuma; T Iwasaka; H Sugimori
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1985-09

6.  Comparison of four new cell lines from patients with adenocarcinoma of the ovary.

Authors:  L K Woods; R T Morgan; L A Quinn; G E Moore; T U Semple; K E Stedman
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

7.  [Establishment and characterization of human ovarian endometrioid carcinoma cell line].

Authors:  S Uehara; K Soh; H Hoshiai; A Yajima; M Suzuki; H Abe
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1983-01

8.  New establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the uterine cervix.

Authors:  M Kawabata
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1984-12

9.  Serum levels of six tumor markers in patients with benign and malignant gynecological disease.

Authors:  I Fukazawa; N Inaba; Y Ota; N Sato; S Shirotake; H Iwasawa; T Sato; H Takamizawa; B Wiklund
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

10.  Immunohistochemical detection of pregnancy-specific protein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11 and PP12) in ovarian adenocarcinomas.

Authors:  N Inaba; H Ishige; M Ijichi; N Satoh; R Ohkawa; S Sekiya; S Shirotake; H Takamizawa; T Renk; H Bohn
Journal:  Oncodev Biol Med       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.